MGAT4FP

Across TCGA pan-cancer cohorts, MGAT4FP RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MGAT4FP data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher MGAT4FP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MGAT4FP expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCEC show a favorable association.

LIHC, SKCM, and HNSC are the cancer types where MGAT4FP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.626	0.788	.006	42	view →
SKCM	OS	Tertile	All	0.796	0.895	.002	33	view →
HNSC	DFS	Tertile	All	0.748	0.668	.016	19	view →
GBM	OS	Tertile	All	0.287	0.436	.006	18	view →
UCEC	DFS	Median	IV	0.827	0.516	.014	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
COAD	OS	Tertile	IV	0.140	0.657	.035	9	view →
ESCA	OS	Tertile	IV	0.743	0.238	.024	6	view →
LGG	OS	Tertile	All	0.851	0.905	.045	6	view →
SARC	DFS	Tertile	All	0.223	0.412	.047	3	view →
KIRC	DFS	Quartile	All	0.523	0.628	.041	1	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MGAT4FP–LIHC (OS)

Open the LIHC breakdown →